Literature DB >> 28944139

A novel CASK mutation identified in siblings exhibiting developmental disorders with/without microcephaly.

Toshiyuki Seto1, Takashi Hamazaki1, Satsuki Nishigaki1, Satoshi Kudo1, Haruo Shintaku1, Yumiko Ondo2, Keiko Shimojima2, Toshiyuki Yamamoto2.   

Abstract

The calcium/calmodulin-dependent serine protein kinase gene (CASK) mutations are associated with various neurological disorders; a syndrome of intellectual disability (ID) and microcephaly with pontine and cerebellar hypoplasia (MICPCH), FG syndrome, X-linked ID with/without nystagmus, epileptic encephalopathy, and autistic spectrum disorder (ASD). Next generation sequencing was performed to elucidate genetic causes in siblings exhibiting developmental disorders, and a novel CASK mutation, c.1424G>T (p.Ser475Ile), was detected in a male patient with ID, ASD, and microcephaly. Radiological examination of his brain showed no structural abnormality. The identified mutation was shared with the healthy mother and a younger sister exhibiting ASD. Although the mother showed a skewed X-chromosome inactivation (XCI) pattern, the sister showed a paradoxical XCI pattern. This would explain why this sister possessed a normal intellectual level, but showed the same ASD symptoms as the affected brother. A novel CASK mutation was identified in two siblings with ID and/or ASD, suggesting a relationship between the CASK mutation and ASD. Recently performed large molecular cohorts for patients with developmental disorders suggest that CASK is one of the genes related to developmental disorders. For better understanding of genotype-phenotype correlation in ASD cases with CASK mutations, more information should be accumulated.

Entities:  

Keywords:  Autism; X-chromosome inactivation; manifesting carrier; next generation sequencing; obligate carrier

Year:  2017        PMID: 28944139      PMCID: PMC5608927          DOI: 10.5582/irdr.2017.01031

Source DB:  PubMed          Journal:  Intractable Rare Dis Res        ISSN: 2186-3644


  19 in total

1.  Mutations of TSEN and CASK genes are prevalent in pontocerebellar hypoplasias type 2 and 4.

Authors:  Vassili Valayannopoulos; Caroline Michot; Diana Rodriguez; Laurence Hubert; Yoann Saillour; Philippe Labrune; Jocelyne de Laveaucoupet; Francis Brunelle; Jeanne Amiel; Stanislas Lyonnet; Ferechté Enza-Razavi; Tania Attié-Bitach; Didier Lacombe; Nadia Bahi-Buisson; Isabelle Desguerre; Jamel Chelly; Lydie Burglen; Nathalie Boddaert; Pascale de Lonlay
Journal:  Brain       Date:  2011-05-23       Impact factor: 13.501

2.  A de novo splice site mutation in CASK causes FG syndrome-4 and congenital nystagmus.

Authors:  P Dunn; G P Prigatano; S Szelinger; J Roth; A L Siniard; A M Claasen; R F Richholt; M De Both; J J Corneveaux; A M Moskowitz; C Balak; I S Piras; M Russell; A L Courtright; N Belnap; S Rangasamy; K Ramsey; J M Opitz; D W Craig; V Narayanan; M J Huentelman; I Schrauwen
Journal:  Am J Med Genet A       Date:  2017-01-31       Impact factor: 2.802

3.  CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes.

Authors:  Anna Hackett; Patrick S Tarpey; Andrea Licata; James Cox; Annabel Whibley; Jackie Boyle; Carolyn Rogers; John Grigg; Michael Partington; Roger E Stevenson; John Tolmie; John Rw Yates; Gillian Turner; Meredith Wilson; Andrew P Futreal; Mark Corbett; Marie Shaw; Jozef Gecz; F Lucy Raymond; Michael R Stratton; Charles E Schwartz; Fatima E Abidi
Journal:  Eur J Hum Genet       Date:  2009-12-23       Impact factor: 4.246

4.  Spectrum of pontocerebellar hypoplasia in 13 girls and boys with CASK mutations: confirmation of a recognizable phenotype and first description of a male mosaic patient.

Authors:  Lydie Burglen; Sandra Chantot-Bastaraud; Catherine Garel; Mathieu Milh; Renaud Touraine; Ginevra Zanni; Florence Petit; Alexandra Afenjar; Cyril Goizet; Sabina Barresi; Aurélie Coussement; Christine Ioos; Leila Lazaro; Sylvie Joriot; Isabelle Desguerre; Didier Lacombe; Vincent des Portes; Enrico Bertini; Jean-Pierre Siffroi; Thierry Billette de Villemeur; Diana Rodriguez
Journal:  Orphanet J Rare Dis       Date:  2012-03-27       Impact factor: 4.123

5.  Comparison of the Kyoto Scale of Psychological Development 2001 with the parent-rated Kinder Infant Development Scale (KIDS).

Authors:  Sayaka Aoki; Keiji Hashimoto; Natsuha Ikeda; Makoto Takekoh; Takeo Fujiwara; Naho Morisaki; Hidetoshi Mezawa; Yoshiyuki Tachibana; Yukihiro Ohya
Journal:  Brain Dev       Date:  2015-11-21       Impact factor: 1.961

6.  A novel TUBB3 mutation in a sporadic patient with asymmetric cortical dysplasia.

Authors:  Keiko Shimojima; Nobuhiko Okamoto; Toshiyuki Yamamoto
Journal:  Am J Med Genet A       Date:  2016-01-06       Impact factor: 2.802

7.  A missense mutation in CASK causes FG syndrome in an Italian family.

Authors:  Giulio Piluso; Francesca D'Amico; Valentina Saccone; Ettore Bismuto; Ida Luisa Rotundo; Marina Di Domenico; Stefania Aurino; Charles E Schwartz; Giovanni Neri; Vincenzo Nigro
Journal:  Am J Hum Genet       Date:  2009-02-05       Impact factor: 11.025

8.  Phenotypic spectrum associated with CASK loss-of-function mutations.

Authors:  Ute Moog; Kerstin Kutsche; Fanny Kortüm; Bettina Chilian; Tatjana Bierhals; Neophytos Apeshiotis; Stefanie Balg; Nicolas Chassaing; Christine Coubes; Soma Das; Hartmut Engels; Hilde Van Esch; Ute Grasshoff; Marisol Heise; Bertrand Isidor; Joanna Jarvis; Udo Koehler; Thomas Martin; Barbara Oehl-Jaschkowitz; Els Ortibus; Daniela T Pilz; Prab Prabhakar; Gudrun Rappold; Isabella Rau; Günther Rettenberger; Gregor Schlüter; Richard H Scott; Moonef Shoukier; Eva Wohlleber; Birgit Zirn; William B Dobyns; Gökhan Uyanik
Journal:  J Med Genet       Date:  2011-09-27       Impact factor: 6.318

9.  The contribution of de novo coding mutations to autism spectrum disorder.

Authors:  Ivan Iossifov; Brian J O'Roak; Stephan J Sanders; Michael Ronemus; Niklas Krumm; Dan Levy; Holly A Stessman; Kali T Witherspoon; Laura Vives; Karynne E Patterson; Joshua D Smith; Bryan Paeper; Deborah A Nickerson; Jeanselle Dea; Shan Dong; Luis E Gonzalez; Jeffrey D Mandell; Shrikant M Mane; Michael T Murtha; Catherine A Sullivan; Michael F Walker; Zainulabedin Waqar; Liping Wei; A Jeremy Willsey; Boris Yamrom; Yoon-ha Lee; Ewa Grabowska; Ertugrul Dalkic; Zihua Wang; Steven Marks; Peter Andrews; Anthony Leotta; Jude Kendall; Inessa Hakker; Julie Rosenbaum; Beicong Ma; Linda Rodgers; Jennifer Troge; Giuseppe Narzisi; Seungtai Yoon; Michael C Schatz; Kenny Ye; W Richard McCombie; Jay Shendure; Evan E Eichler; Matthew W State; Michael Wigler
Journal:  Nature       Date:  2014-10-29       Impact factor: 69.504

10.  Prevalence and architecture of de novo mutations in developmental disorders.

Authors: 
Journal:  Nature       Date:  2017-01-25       Impact factor: 49.962

View more
  4 in total

1.  A de novo variant in CASK gene causing intellectual disability and brain hypoplasia: a case report and literature review.

Authors:  Ying Zhang; Yanyan Nie; Yu Mu; Jie Zheng; Xiaowei Xu; Fang Zhang; Jianbo Shu; Yang Liu
Journal:  Ital J Pediatr       Date:  2022-05-12       Impact factor: 3.288

2.  Case report: A novel CASK mutation in a Chinese female child with microcephaly with pontine and cerebellar hypoplasia.

Authors:  Guilan Xie; Yan Zhang; Wenfang Yang; Liren Yang; Ruiqi Wang; Mengmeng Xu; Landi Sun; Boxing Zhang; Xiaoyi Cui
Journal:  Front Genet       Date:  2022-09-07       Impact factor: 4.772

3.  Case Report: Identification of a novel CASK missense variant in a Chinese family with MICPCH.

Authors:  Runfeng Zhang; Peng Jia; Yanyi Yao; Feng Zhu
Journal:  Front Genet       Date:  2022-08-25       Impact factor: 4.772

4.  Presynaptic dysfunction in CASK-related neurodevelopmental disorders.

Authors:  Martin Becker; Francesca Mastropasqua; Jan Philipp Reising; Simon Maier; Mai-Lan Ho; Ielyzaveta Rabkina; Danyang Li; Janina Neufeld; Lea Ballenberger; Lynnea Myers; Viveka Moritz; Malin Kele; Josephine Wincent; Charlotte Willfors; Rouslan Sitnikov; Eric Herlenius; Britt-Marie Anderlid; Anna Falk; Sven Bölte; Kristiina Tammimies
Journal:  Transl Psychiatry       Date:  2020-09-14       Impact factor: 6.222

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.